The APC1 concept of type I diabetes

Autoimmunity

Volumn 27, Issue 3, 1998, Pages 179-184

  Rothe, Helga ^a,b   Kolb, Hubert ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b LEIBNIZ CENTER FOR DIABETES RESEARCH AT HEINRICH HEINE UNIVERSITY DÜSSELDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; INTERLEUKIN 10; INTERLEUKIN 12; PROSTAGLANDIN E2; TUMOR NECROSIS FACTOR ALPHA;

ANTIGEN PRESENTING CELL; HELPER CELL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULITIS; MACROPHAGE; PANCREAS ISLET CELL; REVIEW; T LYMPHOCYTE;

EID: 0031970927     PISSN: 08916934     EISSN: None     Source Type: Journal    
DOI: 10.3109/08916939809003865     Document Type: Review

References (58)

1. Kolb-Bachofen, V. and Kolb, H. (1989). A role for macrophages in the pathogenesis of type I diabetes. Autoimmunity, 3, 145-155.
2. Leiter, E. H., Prochazka, M. and Coleman, D. L. (1987). Animal model of human disease. The non-obese diabetic (NOD) mouse. Amer J Pathol, 128, 380-391.
3. Scott, J. (1990). The spontaneously diabetic BB rat: sites of the defects leading to autoimmunity and diabetes mellitus. Curr Top Microbiol Immunol, 156, 1-14.
4. Gepts, W. (1965). Pathologic anatomy of pancreas in juvenile diabetes mellitus. Diabetes, 14, 619-633.
5. Oschilewski, U., Kiesel, U. and Kolb, H. (1985). Administration of silica prevents diabetes in BB rats. Diabetes, 34, 197-202.
6. Charlton, B., Bacelj, B. A. and Mandel, T. E. (1988). Administration of silica particals or anti-Lyt2 antibodies prevents β-cell destruction in NOD mice given cyclophosphamide. Diabetes, 37, 930-936.
7. Hahnenberg, H., Kolb-Bachofen, V., Kantwerk-Funke, G. and Kolb, H. (1989). Macrophage infiltration precedes and its prerequisite for lymphocytic insulitis in pancreatic islets of prediabetic BB rats. Diabetologia, 32, 126-129.
8. Lee, K. U., Amano, K. and Yoon, J. W. (1989). Evidence for initial involvement of macrophages in development of insulitis in NOD mice. Diabetes, 37, 989-991.
9. Hutchings, P., Rosen, H. O'Reilly, L., Simpson, E., Gordon, S. and Cooke, A. (1990). Transfer of diabetes in mice is prevented by blockade of adhesion-promoting receptor on macrophages. Nature, 348, 639-642.
10. Voorby, H. A. M., Jeucken, P. H. M., Kabel, P. J., De-Haan, M. and Drexhage, H. A. (1989). Dendritic cells and scavenger macrophages in the pancreatic islets of prediabetic BB rats. Diabetes, 38, 1623-1629.
11. Jansen, A., Homo-Delarche, F., Hooijkaas, H., Leenen, P. J., Dardenne, M. and Drexhage, H. A. (1994). Immunohistochemical characterization of monocyte-macrophages and dendritic cells involved in the initiation of the insulitis and beta-cell destruction in NOD mice. Diabetes, 43, 667-675.
12. Lo, D., Reilly, C. R., Scott, B., Liblau, R., McDevitt, H. O. and Burkly, L. C. (1993). Antigen-presenting cells in adoptively tranferred and spontaneous autoimmune diabetes. Eur J Immunol, 23, 1693-1698.
13. Ziegler, A. G., Erhard, J., Lampeter, E. F., Nagelkerken, L. M. and Standl, E. (1992). Involvement of dendritic cells in early insulitis of BB rats. J Autoimmun, 5, 571-579.
14. Jarpe, A. J., Hickman, M. R., Anderson, J. T., Winter, W. E. and Peck, A. B. (1991). Flow cytometric numeration of mononuklear cell populations infiltrating the islets of Langerhans in prediabetic NOD mice: development of a model of autoimmune insulitis for type I diabetes. Reg Immunol, 3, 305-317.
15. D'Andrea, A., Rengaraju, M., Valiante, N. M., Chehimi, J., Kubin, M., Aste-Amezaga, M.,Chan, S. H., Kobayashi, M., Young, D., Nickbarg, E., Chizzonite, R., Wolf, S. F. and Trinchieri, G. (1992). Production of natural killer cell stimulatory factor (NKSF/IL-12) by peripheral blood mononuklear cells. J Exp Med, 176, 1387-1392.
16. Georgiou, H. M., Constantinou, D. and Mandel, T. E. (1995). Prevention of autoimmunity in nonobese diabetic (NOD) mice by neonatal transfer of allogenic thymic macrophages. Autoimmunity, 21, 89-97.
17. Shimada, A., Takei, I., Mauyama, T., Kasuga, A., Kasatani, T., Watanabe, K., Asaba, Y., Ishii, T., Tadakuma, T. and Habu, S. (1994). Acceleration of diabetes in young NOD mice with peritoneal macrophages. Diabetes Res Clin Pract, 24, 69-76.
18. Boyd, R. L. and Hugo, P. (1991). Towards an intergtated view of thymopoiesis. Immunol Today, 12, 71-79.
19. Serreze, D. V. (1993). Autoimmune diabetes results from genetic defects manifest by antigen presenting cell. FASEB J, 7, 1092-1096.
20. Todd, J. A., Aitman, T. J., Cornall, R. J., Gosh, S., Hall, J. R. S., Hearne, C. M., Knight, A. M., Love, J. M., Mc-Aleer, M. A., Prins, J. B., Rodrigues, N., Lathorp, M., Pressey, A., DeLarto, N. H., Peterson, L. B. and Wicker, L. S. (1991). Genetic analysis of autoimmune type I diabetes mellitus in mice. Nature, 351, 542-547.
21. Davies, J. L., Kawaguchi, Y., Bennett, S. T., Copemann, J. B., Cordell, H. J., Pritchard, L. E., Reed, P. W., Gough, S. C. L., Jenkins, S. C., Palmer, S. M., Balfour, K. M., Rowe, B. R., Farrall, M., Barnett, A. H., Bain, S. C. and Todd, J. A. (1994). A genome-wide search for human type I diabetes susceptible genes. Nature, 371, 130-136.
22. Todd, J. A. and Bain, S. C. (1992). A practical approach to identification of susceptible genes for IDDM. Diabetes, 41, 1029-1034.
23. Rothe, H., Jenkins, N. A., Copeland, N. G. and Kolb, H. (1997). Active stage of autoimmune diabetes is associated with the expression of a novel cytokine, IGIF. which is located near Idd2. J Clin Invest., 99, 469-474.
24. Jenkins, N. A., Rothe, H., Gilbert, D. J., Copeland, N. G. and Kolb, H. (1994). Mapping of the gene for inducible NO symthase of mouse macrophages to chromosome 11 close to evi-2, nu and Idd-4. Genomics, 19, 402-405.
25. Ballantyne, C. M., Kozak, C. A., O'Brien, W. E. and Beaudet, A. L. (1991). Assignment of the gene for intercellular adhesion molecul-1 (ICAM-1) to proximal mouse chromosome 9. Genomics, 9, 547-550.
26. Russel, P. J. and Steinberg, A. D. (1983). Sudies of peritoneal macrophage function in mice with systemic lupus erythematosus: depressed phagocytosis of opsonized sheep erythrocytes in vitro. Clin Immunol Immunophathol, 27, 387-402.
27. Luqmani, R., Sheeran, T., Robinson, M., Richardson, K., Winkels, J. and Emery, P. (1994). Sytemic cytokine measurements: their role in monitoring the response to therapy in patients with rheumatois arthritis. Clin Exp Rheumatol, 12, 503-508.
28. Serreze, D. V., Gaskin, H. R. and Leiter, E. H. (1993). Defects in differentiation and function of antigen presenting cells in NOD/Lt mice. J Immunol, 150, 2534-2543.
29. Jacob, C. O., Aiso, S. and Michie, S. A. (1990). Prevention of diabetes in nonobese diabetic mice by tumor necrosis factor (TNF): Similiarities between TNFα and interleukin 1. Immunology, 87, 968-972.
30. Lapchak, P. H., Guilbert, L. J. and Rabinovitch, A. (1992). Tumor necrosis factor production is deficient in diabetesprone BB rats and can be corrected by complete Freund's adjuvant: A possible immunoregulatory role of tumor necrosis factor in the prevention of diabetes. Clin Immunol. Immunopathol, 65, 129-134.
31. Barel, D., Brennan, D. C. and Jevnikar, A. M. (1992). Enhanced tumor necrosis factor in anti-CD3 antibody stimulated diabetic NOD mice: Modulation by PGE1 and dietary lipid. Autoimmunity, 13, 141-149.
32. Rothe, H., Fehsel, K. and Kolb, H. (1990). A macrophage defect in diabetes prone BB rats. Diabetologia, 33, 573-575.
33. 2 feedback inhibition. Immunology, 81, 407-413.
34. Rothe, H., Öngören, C., Rösen, P. and Kolb, H. (1993). Genetic analysis of aberrant TNFα production in prediabetic BB rats. Transplantation Proceedings, 25, 2833.
35. Mosmann, T. R., Cherwinski, I. I., Bond, M. W., Giedlin, M. A. and Coffman, R. L. (1986). Two types of murine helper T cell clones. I. Definition according to profiles of lymphokine activities and secreted proteins. J'Immunol, 185, 2348-2357.
36. Mosmann, T. R. and Coffman, R. L. (1989). Th1 and Th2 cells different patterns of lymphokine secretion to different functional properties. Annual Rev Immunol, 7, 145-173
37. Shehadeh, N. N., LaRosa, L. and Lafferty, K. J. (1993). Altered cytokine activity in adjuvant inhibition of autoimmune diabetes. J Autoimmun, 6, 291-300.
38. Rothe, H., Faust, H., Schade, U., Kleemann, R., Bosse, G., Hibino, T., Martin, S. and Kolb, H. (1994). Acceleration of diabetes development in NOD mice by cyclophosphamide is associated with a shift from IL-4 to IFN-gamma production and with enhanced expression of inducible NO-synthase in pancreatic lesions. Diabetologia, 37, 1154-1158.
39. Rabinovilch, A. (1994). Immunoregulatory and cytokine imbalances in the pathogenesis of IDDM. Diabetes, 43, 613-621.
40. Katz, J. D., Benoist, C. and Mathis, D. (1995). T helper cell subsets in insulin-dependent diabetes. Science, 268, 1185-1188.
41. Healey, D., Ozegbe, P., Arden, S., Chandler, P., Hutchton, J. and Cooke, A. (1995). In vivo and in vitro specificity of CD4+ Th1 and Th2 cells derived from the spleens of diabetic NOD mice. J Clin Invest, 95, 2979-2985.
42. Hancock, W. W., Polanski, M., Zhang, J., Blogg, N. and Weiner, H. L. (1995). Suppression of insulitis in non-obese diabetic (NOD) mice by oral insulin administration is associated with selective expression of interleukin-4 and -10, transforming growth factor, an prostaglandine-E. Am J Pathol, 147, 1193-1199.
43. Okamura, H., Tsutsui, H., Komatsu, T., Yutsudo, M., Hakura, A., Tanimoto, T., Torigoe, K., Okura, T., Nukada, Y., Hattori, K., Akita, K., Namba, M., Tanabe, F., Konishi, K., Fukuda, S. and Kurimoto, M. (1994). Cloning of a new cytokine that induces IFN-γ production by T cells. Nature, 378, 88-91.
44. Wolf, S. F., Temple, P. A., Kobayashi, M., Young, D., Dicig, M., Lowe, L., et al. (1991). Cloning of cDNA for natural killer stimulatory factor, a hetrodimeric cytokine with multiple biological effects on T and natural killer cells. J Immunol, 146, 3074-3081.
45. Gubler. U., Chua, A. O., Schoenhaut, D. S., Dwyer, C.M., MaComas, W., Motyka, R., et al. (1991). Co-expression of two distinct genes is required to generate secreted bioactive cycotoxic lymphocyte maturation factor. Proc Natl Acad Sci, 88, 4143-4147.
46. Hsieh, C. S., Macatonia, S. E., Tripp, C. S., Wolf, S. F., O'Garra, A. and Murphy, K. M. (1993). Development of Th1 CD4+ T cells through IL-12 produced by Listeria-induced macorphages. Science, 260, 547-549.
47. Manetti, R., Parronchi, P., Giudizi, M. C., Piccini, M. P., Maggi, E., Trinchieri, G., et al. (1993). Natural killer cell stimulatory factor (interleukin-12) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4 producing Th cells. J Exp Med., 177, 1199-1204.
48. Alfoso, L. C. C., Scharton, T. M., Vieira, L. Q., Wysocka, M., Trinchieri, G. and Scott, P. (1994). The adjuvant effect of interleukin-12 in a vaccine against Leishmania major. Science, 263, 235-237.
49. Trembleau, S., Penna, G., Bosi, E., Mortara, A., Gately, M. K. and Adorini, L. (1995). Interleukin -12 administration induces T helper type I cells and accelerates autoimmune diabetes in NOD mice. J Exp Med, 181, 817-821.
50. Micallef, M. J., Ohtsuki, T., Kohno, K., Tanabe, F., Ushio, S., Namba, M., Tanimoto, T., Torigoe, K., Fujii, M., Ikeda, M. M., Fukuda, S. and Kurimoto, M. (1996). Interferon-gamma-inducing factor enhances T helper I cytokine production by stimulated human T cells: synergism with interleukin-12 for interferon-gamma production. Eur J Immunol, 26, 1647-1651.
51. Rothe, H., Burkart, V., Faust, A. and Kolb, H. (1996). Interleukin-12 gene expression is associated with rapid diabetes development in NOD mice. Diabetologia, 39, 119-122.
52. Powrie, F., Menon, S. and Coffman, R. L. (1993). Interleukin-4 and interleukin-10 synergize to inhibit cell mediated immunity in vivo. Eur J Immunol, 23, 3043-3049.
53. Fiorentino, D. F., Zlotnik, A., Vieira, P., Mosmann, T. R., Howard, M., Moore, K. W. and O'Garra, A. (1991). IL-10 acts on the antigen presenting cell to inhibit cytokine production by ThI cells. J Immunol, 146, 3444-3451.
54. Dandrea, A., Asteamezaga, M., Valiante, N. M., Ma, X. J., Kubin, M. and Trinchieri, G. (1993). Interleukin-10 (IL-10) inhibits human lymphocyte interferon-gamma production by suppressing natural killer stimulatory factor/IL-12 synthesis in accessory cells. J. Exp. Med., 178, 1041-1048.
55. Bogdan, C., Vodovotz, Y. and Nathan, C. (1991). Macrophage deactivation by interleukin 10. J Exp Med, 174, 1549-1555.
56. Moore, K., O'Garra, A., De Wal Malefyt, R., Vieira, P. and Mosmann, T. R. (1993). Interleukin-10. Annual Rev Immunol, 11, 165-190.
57. Pennline, K. J., Roquegaffney, E. and Monahan, M. (1994). Recombinant human IL-10 prevents the onset of diabetes in nonobese diabetic mouse. Clin Immunol Immunopathol, 71, 169-175.
58. Rabinovitch, A., Sorensen, O., Suarez-Pinzon, W. L., Power, R. F., Rajotte, R. V. and Bleackey, R. C. (1994). Analysis of cytokine mRNA expression in syngeneic islet grafts of NOD mice:interleukin-2 and interferone-γ mRNA expression correlate with graft injection and interleukin-10 with graft survival. Diabetologia.